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PURPOSE. Abnormal choroidal blood flow is considered important in the pathogenesis of
chronic central serous chorioretinopathy (CSC). Optical coherence tomography (OCT)
angiography can image ocular blood cell flow and could thus provide novel insights in disease
mechanisms of CSC. We evaluated depth-resolved flow in chronic CSC by OCT angiography
compared to fluorescein angiography (FA) and indocyanine green angiography (ICGA).
METHODS. Eighteen eyes with chronic CSC, and six healthy controls, were included. Two
human observers annotated areas of staining, hypofluorescence, and hotspots on FA and
ICGA, and areas of abnormal flow on OCT angiography. Interobserver agreement in
annotating OCT angiography and FA/ICGA was measured by Jaccard indices (JIs). We assessed
colocation of flow abnormalities and subretinal fluid visible on OCT, and the distance
between hotspots on ICGA from flow abnormalities.
RESULTS. Abnormal areas were most frequently annotated in late-phase ICGA and
choriocapillary OCT angiography, with moderately high (median JI, 0.74) and moderate
(median JI, 0.52) interobserver agreement, respectively. Abnormalities on late-phase ICGA and
FA colocated with those on OCT angiography. Aberrant choriocapillary OCT angiography
presented as foci of reduced flow surrounded by hyperperfused areas. Hotspots on ICGA
were located near hypoperfused spots on OCT angiography (mean distance, 168 lm). Areas
with current or former subretinal fluid were colocated with flow abnormalities.
CONCLUSIONS. On OCT angiography, chronic CSC showed irregular choriocapillary flow
patterns, corresponding to ICGA abnormalities. These results suggest focal choriocapillary
ischemia with surrounding hyperperfusion that may lead to subretinal fluid leakage.
Keywords: OCT angiography, split-spectrum amplitude decorrelation angiography, SSADA,
chronic central serous chorioretinopathy, choriocapillary flow, optical coherence
tomography
Central serous chorioretinopathy (CSC) is characterized by aserous retinal detachment, sometimes accompanied by a
detachment of the retinal pigment epithelium (RPE).1–4 The
leakage of fluid through the RPE often occurs at the macula,
resulting in central vision loss, disturbed color vision, (para-)
central scotoma, metamorphopsia, and/or micropsia.2,4–6 Pa-
tients with CSC are typically male (male to female ratio, 6:1),
with an average age of 45 to 51 years.1,3 Besides the male sex,
the most consistent risk factor appears to be the use of
corticosteroids, as well as circumstances where corticosteroid
levels are increased, such as Cushing disease and pregnancy. In
addition, a type A personality and certain genetic factors may
increase the risk for CSC.1,7,8 Although the precise pathophys-
iologic mechanism is still unclear, multimodal imaging indicates
that subretinal fluid (SRF) accumulation in CSC results from a
thickened, congested, hyperpermeable choroid leaking fluid
through a dysfunctional RPE.9–12
Two main forms of CSC can be distinguished: the acute and
chronic form.1,3,4,11 Patients with acute CSC usually present
with sudden and marked central vision loss, caused by SRF
leakage at the macula due to a focal leak in the RPE that is
visible on fluorescein angiography (FA).1,2,13 The prognosis is
favorable in this type and spontaneous recovery is often seen
within 2 to 3 months.1 In contrast to acute CSC, chronic CSC is
typically not self-limiting and SRF persists for more than 3
months. Patients with chronic CSC have more diffuse multifocal
leakage on FA and indocyanine green angiography (ICGA), as
well as irregularly distributed widespread RPE changes
associated with various degrees of low-grade, more distinct
leakage on angiography: diffuse retinal pigment epitheliopathy
(DRPE). Such persistent serous neuroretinal detachments may
cause progressive and irreversible photoreceptor damage,
resulting in a far worse visual prognosis of chronic CSC as
compared to the acute form.2,14,15
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Previous studies10 have examined blood flow in CSC by use
of FA/ICGA imaging and observed choriocapillary congestion.
In an ultrastructural study of a cynomolgus monkey model of
CSC, damage of choriocapillary endothelial cells underneath
damaged RPE cells that were covered by fibrin platelet clots
has been observed, which led to the suggestion that
choriocapillary hyperpermeability occurs in CSC.16,17 Blood
flow in CSC has also been examined with other optical imaging
modalities. For instance, choroidal hypoperfusion has been
demonstrated with laser Doppler flowmetry.18
Spectral-domain optical coherence tomography (SD-OCT) is
a noninvasive, high-speed, high-resolution, three-dimensional
imaging technique frequently applied in patients with CSC to
evaluate SRF and photoreceptor damage.19 Spectral-domain
OCT may also be used to perform angiography in a noninvasive
manner. Split-spectrum amplitude decorrelation angiography
(SSADA) is a clinically feasible, commercialized technique that
can visualize capillary blood flow, but without determination
of the flow direction.20 In contrast to dye-assisted FA and ICGA
imaging, OCT angiography detects movements of blood cells,
instead of serum extravasation or staining of vessel walls and
tissue. Split-spectrum amplitude decorrelation angiography has
been used recently in the examination of abnormal vascular
structures in macular telangiectasia type 2,21 and of choroidal
neovascularization in age-related macular degeneration,22,23 as
well as chronic CSC.24 Hence, OCT angiography could provide
additional information on the blood supply in CSC, and it could
therefore help to better understand the underlying pathophys-
iology of the disease. In our current study we compared OCT
angiography in chronic CSC to established angiographic
imaging modalities such as FA and ICGA.
METHODS
We studied 18 eyes of 11 consecutive patients (6 male, 5
female) with chronic CSC seen at the outpatient clinic of the
Department of Ophthalmology of the Radboud University
Medical Center (Nijmegen, The Netherlands) from November
2014 to January 2015. All study participants gave oral informed
consent for OCT-based angiography imaging. In addition, six
healthy volunteers (three male, three female) with no medical
history of ocular or cardiovascular diseases and/or diabetes
mellitus served as controls. Ethical approval for retrospective
analysis of this observational case series was granted by the
institutional review board at the Radboud University Medical
Center and the study adhered to the tenets of the Declaration
of Helsinki. The diagnosis of chronic CSC was based on a
history with persistent fluid of at least 3 months’ duration, as
well as RPE damage (DRPE) due to longstanding SRF. Active
chronic CSC was defined by active leakage of fluid under the
neuroretina confirmed by SD-OCT and by hyperfluorescent
spots on ICGA and/or at least one ill-defined leakage spot on
FA. Patients were included if OCT angiography, FA, and ICGA
were performed on the same day to maximize the compara-
bility of the angiographic techniques. Patients with other
ocular disorders commonly associated with serous SRF, such as
choroidal neovascularization, polypoidal choroidal vasculop-
athy, diabetic retinopathy, retinal vascular occlusion, and
myopia > 6 diopters were not eligible.
For SD-OCT, fundus autofluorescence (AF), FA and ICGA
imaging, we used the Spectralis HRAþOCT device (Heidelberg
Engineering, Heidelberg, Germany). Simultaneous FA and ICGA
imaging were performed after patients were given a 2.5-mL
intravenous injection of 25% fluorescein solution mixed with
12.5 mg indocyanine green (ICG-Pulsion, 25 mg; Pulsion
Medical Systems SE, Feldkirchen, Germany). Fluorescein
angiography and accompanying ICGA images were selected
from the early phase (30–60 seconds post injection) and the
late phase (6–8 minutes post injection) of the dye transit.
Following ICGA/FA imaging, the presence of submacular fluid
deposits was evaluated by SD-OCT.
OCT Angiography
We used a newly developed SD-OCT device (OptoVue RTVue
XR Avanti AngioVue; Optovue, Inc., Fremont, CA, USA) to
obtain SSADA images. This instrument has an A-scan rate of 70
kHz and an axial resolution in tissue of 5 lm, using a light
source with a center wavelength of 840 nm and a spectral
bandwidth of 45 nm. Two consecutive B-scans (M-B frames) of
304 A-scans each along the fast-scanning axis were recorded at
each of the 304 positions along the slow-scanning axis.
According to this protocol, horizontal priority fast transverse
(x-fast) scans and vertical priority fast transverse (y-fast) scans
were obtained consecutively to record a three-dimensional
data cube. The M-B frames were analyzed for highly
decorrelated pixels, which are colocated with moving blood
cells in retinal and choroidal vessels. These data were used to
reconstruct three-dimensional blood flow images as described
previously.20 Scans with insufficient quality due to blinking
(appearing as straight, black stripes), or fixation loss, were
excluded. After selecting the best scans, residual axial and
saccadic motion artifacts were corrected by using the
contained software (ReVue; Optovue, Inc.). The OCT angiog-
raphy images of four vascular layers (inner vascular plexus,
deep retinal vascular plexus, outer retina, and choriocapillaris),
and a full-thickness OCT angiogram including all retinal layers
and the choriocapillaris, were then exported. Examples of
these images in a healthy control subject (Figs. 1A–D) and a
patient with chronic CSC (Figs. 1E–H) are depicted in Figure 1.
Image Readings and Annotations
The OCT angiography images and FA/ICGA images were
aligned by using a semiautomatic registration tool, developed
in MeVisLab (version 2.5a; MeVis Medical Solutions AG,
Bremen, Germany), that translates, rotates, and rescales the
target image to accurately match three user-specified landmark
locations on both the source (FA) and target (OCT angiography
of the superficial layer) images.25 The same transformation
matrix was applied to ICGA images for coregistration.
All image readings were performed at NANOREAD (Nijme-
gen Angio OCT Reading Center) by experienced and masked
observers, and were done separately on the same computer.
Each observer (MBB, TT) annotated areas showing leakage and
hypofluorescence in the FA and ICGA images and regions in
the OCT angiography images with visually evident deviations
from the normal appearance. In Figure 2, the image registration
and annotation processes are depicted in a flowchart together
with illustrative examples. A representative example of
registered images is shown in Figure 3. The OCT angiography
images of five healthy volunteers, who were not part of the
study, served as a reference. Images of patients and controls
were anonymized and randomized, by replacing filenames with
unique random numbers and subsequent sequential rearrange-
ment according to consecutive numbering. The region-of-
interest (ROI) function of ImageJ (version 1.46r; http://imagej.
nih.gov/ij/; provided in the public domain by the National
Institutes of Health, Bethesda, MD, USA) was used for
annotation purposes.
Image Analysis
To determine the interobserver agreement of image annota-
tions, the number of images annotated by both observers was
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determined. In case both observers annotated the image, we
calculated the spatial overlap of the annotations by the Jaccard
index (JI) as follows:
JIðR1; R2Þ ¼
R1 pixels˙R2 pixels
R1 pixels¨R2 pixels
:
Indices were calculated separately for each observer’s set of
annotations and were then pooled together. The spatial
correspondence of abnormalities visible in OCT angiography
images with FA/ICGA was firstly determined by the frequency
of annotations on both modalities. In those cases, we calculated
JIs to determine the extent of their overlap. We tested if the
overlap of each combination of OCT angiography images and
FA/ICGA images was different from all other combinations with
the Mann-Whitney U test. We also tested if this overlap, in
terms of JIs, was correlated between both eyes of a patient. P
values < 0.05 were considered statistically significant.
Image analysis was performed to determine the correspon-
dence between hotspots or profound hypofluorescence in late-
phase ICGA images, and focal areas of decreased flow in the
choriocapillary lamina on OCT angiography images, in terms of
the distance between their centers. These centers were
determined by the center of mass of the annotated areas. In
case adjacent foci appeared confluent on ICGA images, they
were often amalgamated in a single ROI as ‘‘beads on a string.’’
A watershed algorithm was applied to split these ROIs to
facilitate the distinction of different foci. Subsequently, the
shortest distances between leakage hotspots or hypofluorescent
foci in ICGA images and dark spots in OCT angiography images
with a visually evident correspondence were calculated (Fig. 4).
Fundus Autofluorescence
To determine whether the results of OCT angiography of the
choriocapillaris were affected by light-absorbing chromo-
phores of the RPE, we compared OCT angiography images to
AF images that were recorded on the same day. The AF images
were registered to OCT angiography images as described
earlier. We considered OCT angiography signals above or
below the mean 6 2 standard deviations of apparently
uninvolved areas as abnormal choriocapillary flow. Uninvolved
areas were determined by a lack of annotations, absence of
large vessel shadows, and in the near vicinity of the image
border, as irregular flow at the image borders was common
even in healthy subjects. Thresholded pixels of increased or
decreased flow were overlaid on the registered AF images.
Finally, two observers (MMT, TT) evaluated whether there was
any colocation of focally changed AF signals and choriocapil-
lary flow.
RESULTS
Patient demographics are depicted in Table 1.
Interobserver Agreement
A total of 255 images were analyzed, including 100 FA and
ICGA images of patients, and 125 and 30 OCT angiography
images of patients and healthy subjects, respectively. In 132
images (52%), abnormalities were annotated by both observers
(83 FA/ICGA images and 49 OCT angiography images). An
example of image annotations by both observers is shown in
Figure 5. The corresponding JIs as indicators of interobserver
agreement and numbers of annotated images are summarized
in Table 2. The FA and ICGA images were annotated with
moderate agreement (median JIs, 0.43–0.67). Of the various
OCT angiography images, choriocapillary flow images were
most frequently annotated by both observers (80% of the
patient images, 17% of the control images) with moderate
interobserver agreement (median JI, 0.52). The OCT angiogra-
phy images of retinal layers were annotated less often than
choriocapillary flow images. The interobserver agreement in
FIGURE 1. Optical coherence tomography angiography of a healthy subject and of a patient with chronic CSC. (A–D) Right eye of a healthy 25-year-
old female. (E–H) Left eye of a patient with chronic CSC (patient 4, see Table 1). (A, E) The inner vascular plexus (‘‘superficial’’). (B, F) The deep
retinal vascular plexus (‘‘deep’’). (C, G) Choriocapillaris (‘‘choroid cap’’). The choriocapillaris was defined as a 20-lm band below the RPE–Bruch’s
membrane complex. It was segmented by the ReVue software and, if needed, corrected for significant segmentation errors. (D, H) Full-thickness
OCT angiogram. Outer retina not shown.
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annotating abnormal choriocapillary flow was similar to FA and
ICGA, both in terms of the frequency of annotations and the
agreement scores.
General Correspondence Between OCT
Angiography and FA/ICGA
Table 3 summarizes the overlap of annotated abnormal areas
observed with various angiographic imaging modalities ex-
pressed in JIs. Choriocapillary flow images and late-phase FA/
ICGA images corresponded best in determining abnormality
with moderately low overlap of the annotated areas (median JI
of both FA and ICGA versus choriocapillary, 0.41). In general,
there was a poor overlap between annotated changes on FA
and OCT angiography images, with median JIs ranging from 0
to 0.05. The correspondence between aberrant choriocapillary
FIGURE 2. Flowchart of the image registration and annotation procedures. Original images, that is, superficial retinal OCT angiography and FA
images, were registered by an observer, using a variety of image overlay options (step 1). Simultaneously acquired ICGA images were transformed
identically to the FA image (step 2). The final display image, with a standard layout, was then created, which included the original FA/ICGA image
containing contextual information (step 3). Annotations were made by human observers (step 4), after which the overlap of annotations was
calculated by Jaccard’s index (step 5). See text for details.
FIGURE 3. Example of image registration. Overlay of an early-phase FA
image (red) registered to a superficial OCT angiography image (green),
with overlapping vessels indicated in yellow.
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flow and abnormalities on late-phase FA/ICGA was higher than
the correspondence of abnormalities in early or late FA images
and abnormalities in retinal OCT angiography images (P <
0.001). In general, the JIs showed a significant correlation
between both eyes (Spearman’s q ¼ 0.59, P ¼ 4.5107).
The annotated choriocapillary flow patterns had a highly
variable appearance. In some cases, we observed mottled flow
patterns with patches of increased and decreased flow. Mostly,
however, we observed irregular patterns with large and
semiconfluent patches of decreased flow adjacent to similar
patches with increased flow. A small number of patches with
decreased choriocapillary flow corresponded with RPE de-
tachments visible on SD-OCT. Several other patches corre-
sponded with focal areas of a thickened RPE below an SRF
pocket, which appeared to produce shadow artifacts on late-
phase ICGA. In general, light-absorbing fluorophores in the
RPE, as visualized by AF imaging, had no apparent correspon-
dence with the appearance of choriocapillary flow on OCT
angiography of CSC. A few sporadic hyper-AF areas corre-
sponded with decreased flow areas, although not all hyper-AF
in the same images corresponded with decreased flow and
vice-versa. The same was true for the correspondence between
hypo-AF and increased flow, and for other combinations. Areas
of aberrant choriocapillary flow were generally colocated with
locations of current SRF accumulation visible on SD-OCT, or
with locations where SRF had resolved. The aberrant flow
patterns appeared similarly heterogeneous in treatment-naive
patients and treated subjects, with no consistent differences in
eyes that received micropulse laser treatment or photodynamic
therapy.
Correspondence Between Hotspots on ICGA and
Aberrant Choriocapillary Flow
We also studied the relationship between decreased chorioca-
pillary flow and hotspots or hypofluorescence on ICGA (Fig.
FIGURE 4. Annotation and quantitative analysis of hyperfluorescent areas on ICGA and aberrant flow on OCT angiography. Left image: Late-phase
ICGA image of a patient with chronic CSC with location of the registered image (yellow frame). Middle image: Detail of abnormalities in the
registered ICGA image. Right image: The aberrant flow pattern on OCT angiography of the choriocapillaris is colocated with the annotated region
on late-phase ICGA; the darkest region corresponds with a hypofluorescent spot on ICGA, bordered by increased flow colocated to the leakage
hotspot and late staining. The annotated region is depicted by the yellow line.
TABLE 1. Clinical Characteristics of the Patients Included in This Study
ID/Sex/Age, y
Eye(s)
Included
Signs of Chronic
CSC on FA,
ICGA, and OCT
Active Chronic
CSC on FA,
ICGA, and OCT
Previous
Treatment(s)
P1/F/55 OD Yes Yes 1 3 MP
P2/M/58 OD Yes Yes NA
P3/F/64 OD Yes Yes NA
OS Yes Yes NA
P4/M/40 OD Yes No NA
OS Yes Yes NA
P5/M/71 OD Yes No 2 3 PDT
P6/F/56 OD Yes Yes NA
P7/F/38 OD Yes No NA
OS Yes Yes 1 3 PDT
P8/F/56 OD Yes No 1 3 MP
OS Yes Yes NA
P9/M/59 OD Yes Yes 2 3 MP, 1 3 PDT
OS No No NA
P10/M/62 OD No No NA
OS Yes Yes NA
P11/M/47 OD Yes Yes NA
OS Yes No 2 3 MP, 1 3 PDT
F, female; M, male; MP, micropulse laser therapy; NA, not applicable; OD, right eye; OS, left eye; PDT, half-dose photodynamic therapy.
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FIGURE 5. Examples of image annotations. (A, B) Late-phase ICGA images (left eye of patient 8, 63 6 mm). (C, D) Superficial OCT angiography
images. (E, F) Deep OCT angiography images. (G, H) Choriocapillary OCT angiography images. Left column: Annotations by observer 1. Right
column: Annotations by observer 2. The JIs of overlap between late-phase ICGA and superficial- and deep-OCT angiography were 0.006 and 0.022,
respectively (observer 2). The JIs of overlap of late-phase ICGA with choriocapillary OCT angiography were 0.43 and 0.55 for observers 1 and 2,
respectively.
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4). In most areas with decreased flow on OCT angiography we
were unable to observe a corresponding, well-defined focus of
abnormal fluorescence on late-phase ICGA (75 of 117 areas, or
64.1%). The remaining areas with decreased flow, however,
overlapped largely with hypofuorescent areas on ICGA. Twelve
(29.3%) of 41 leakage areas and hotspots on late-phase ICGA
appeared to be connected with areas of decreased chorioca-
pillary flow on OCT angiography, versus 24 (42.9%) of 56
hypofluorescent spots on late-phase ICGA. The mean distance
between hotspots on ICGA and matched areas with decreased
signal in choriocapillary flow images on OCT angiography was
168 lm (SD, 133 lm), or 17 pixels. The mean distance of
hypofluorescent spots was 133 lm (SD, 70 lm), or 13 pixels.
Areas of increased flow, however, were often found adjacent to
leakage hotspots on ICGA. For choriocapillary flow images and
corresponding FA/ICGA and AF images of all included patients
and controls, see Supplementary Figure S1.
DISCUSSION
In this study, we compared OCT angiography characteristics of
patients with chronic CSC to FA and ICGA findings. We found
typical changes in the choriocapillary flow pattern of chronic
CSC patients, which corresponded to areas affected by SRF
accumulation. There was moderate interobserver agreement
on changes in choriocapillary flow images of CSC patients, and
there was moderate spatial correspondence between late FA/
ICGA and choriocapillary flow images.
Kitaya et al.18 have used laser Doppler flowmetry to show
that eyes with CSC have reduced choroidal blood flow relative
to the unaffected fellow eye. Using combined FA/ICGA
imaging, Scheider et al.26 also have confirmed the reduction
in choroidal blood flow in CSC and demonstrated that the
hypoperfusion persists after clinical improvement. In our
study, changes of the choriocapillary flow pattern on OCT
angiography appeared as focally increased and decreased pixel
values, indicating coexisting increased and decreased flow,
respectively. Even though the appearance of these changes was
significantly different from the fairly homogeneous appearance
of the healthy choriocapillary layer, there was only a moderate
interobserver agreement. Obviously, the border between the
appearance of healthy and affected tissue in OCT angiography
may not easily be drawn between observers. This phenomenon
has been observed earlier in a study that evaluated the
agreement among highly experienced retinal specialists in
grading of FA images for the presence of active choroidal
neovascularization.27 A multimodal approach in angiographic
techniques may help to improve the identification of patho-
logic changes. One has to keep in mind, however, that OCT
angiography measures blood flow dependent on intravascular
cell movements, while FA/ICGA images the flow of blood
plasma, independent of cell movement. Therefore, these three
techniques give blood flow information that is supplementary
to each other.
On OCT angiography, we observed choriocapillary hypo-
perfusion with hyperperfusion in the surrounding area. This is
consistent with results of earlier studies, showing focal filling
defects in the choriocapillaris with dilated and tortuous feeding
arterioles and dilated venules.10,28–30 These filling defects may
be caused by capillary congestion and/or rarefaction.10 Areas
of irregular choriocapillary texture on OCT angiography
partially colocated to areas with late staining on ICGA. Also,
many hotspots on late-phase ICGA, if present, were in close
proximity of relative ischemia on OCT angiography within
those areas of irregular texture. Taken together, these data
suggest that reduced blood perfusion in the choriocapillaris
may be surrounded by reactive hyperperfusion. Hyperperfu-
sion leads to increased hydrostatic pressure within the
fenestrated choriocapillaris. Together with chronic hypoxic
damage, this may lead to disintegrity of the continuity of the
RPE,31 and to SRF leakage with serous neuroretinal detachment
in chronic CSC.32,33
According to our data, the abnormal vascular situation in
the choriocapillary layer appeared to persist even after
resolution of SRF and seemed to be independent of any kind
of treatment. It is still unclear why different treatment
modalities may lead to successful fluid resorption. The
mechanism of action of photodynamic therapy has been
postulated to include short-term choriocapillary hypoperfusion
and long-term choroidal vascular remodeling with subsequent
reduction of vascular hyperpermeability and leakage.19,34,35 On
the short term, the hypoperfusion may lead to more ischemic
RPE damage. Because of the long period between photody-
namic therapy and our study measurements, we may have
missed any therapeutic effects visible on OCT angiography. It
may be useful to prospectively follow up patients after
photodynamic therapy by OCT angiography to learn more
about the therapeutic mechanism of this treatment. Subthresh-
old micropulse diode laser treatment is applied in an attempt
TABLE 2. Interobserver Agreement of Annotated Vascular Abnormal-
ities in FA, ICGA, and OCT Angiography Images
JI
Annotations Made
by Observers
Mean (SD) Median Both Either None
FA/ICGA
FA, early phase 0.46 (0.29) 0.35 19 1 5
FA, late phase 0.59 (0.23) 0.58 20 2 3
ICGA, early phase 0.43 (0.29) 0.47 22 1 2
ICGA, late phase 0.67 (0.15) 0.74 22 2 1
OCT angiography
Superficial 0.28 (0.22) 0.28 4 9 18
Deep 0.27 (0.19) 0.26 11 10 10
Outer retina 0.47 (0.17) 0.40 7 16 8
Choroid cap 0.49 (0.22) 0.52 21 5 5
FT-OCTA 0.5 (0.2) 0.53 6 11 14
Choroid cap, choriocapillaris; FT-OCTA, full-thickness OCT angio-
gram; SD, standard deviation.
TABLE 3. Overlap of Image Annotations on FA/ICGA and OCT
Angiography in 11 Patients With Chronic CSC
FA/ ICGA
OCT
Angiography Mean JI (SD) Median
FA, early phase Superficial 0.04 (0.1) 0
Deep 0.06 (0.1) 0.01
Choroid cap 0.25 (0.21) 0.22
FT-OCTA 0.1 (0.19) 0
FA, late phase Superficial 0.03 (0.06) 0
Deep 0.09 (0.14) 0.02
Choroid cap 0.38 (0.22) 0.41
FT-OCTA 0.11 (0.15) 0.05
ICGA, early phase Superficial 0.12 (0.2) 0
Deep 0.09 (0.12) 0.04
Choroid cap 0.27 (0.18) 0.24
FT-OCTA 0.1 (0.15) 0.05
ICGA, late phase Superficial 0.04 (0.06) 0
Deep 0.08 (0.11) 0.05
Choroid cap 0.41 (0.19) 0.41
FT-OCTA 0.14 (0.2) 0.05
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to trigger the regeneration of the RPE and a long-term
metabolic increase at the chorioretinal junction,36 which may
increase SRF resorption by the RPE.37 Micropulse laser
treatment is not thought to affect the choriocapillaris directly.
The lack of effects on choriocapillary flow in patients after
micropulse laser treatment is therefore not surprising.
Our study was mainly limited by the small number of
patients and the retrospective and cross-sectional data acqui-
sition. As a consequence, we have studied a combination of
treatment-naive patients and patients who were previously
treated by micropulse laser or photodynamic therapy once or
multiple times. We do not have pretreatment data and we did
not monitor patients over time. To further improve our
knowledge of the vascular changes in chronic CSC, prospective
and longitudinal studies are required to monitor vascular
changes during the natural course and during different
treatment strategies. Although we found no consistent effects
of chromophores in the RPE on the appearance of choriocapil-
lary flow, save for a few sporadic cases, a comprehensive
analysis of potential confounders on the appearance of OCT
angiography signals was out of the scope of this study. This is
important in OCT angiography studies of retinal diseases in
which layers with high light-absorption are affected. Therefore,
future studies should include SD-OCT and AF imaging to
determine potential imaging artifacts. The fields of view on
OCT angiography were of considerably smaller size than those
currently used in ICGA or SD-OCT. Peripheral areas with
obvious FA/ICGA irregularities were therefore missed. Future
studies should aim to include the complete posterior pole with
all angiographic abnormalities by OCT angiography scanning.
This could be achieved by a montage of many high-resolution
OCT angiography scans or by improved OCT hardware–
software combinations capable of visualizing larger fundus
areas with high resolution.
In conclusion, OCT angiography showed significant textural
changes of the choriocapillary flow pattern in chronic CSC
patients. Our results suggest foci of ischemia surrounded by
reactive choroidal hyperperfusion as an important factor in the
pathogenesis of chronic CSC. Prospective OCT angiography
studies on chronic CSC are needed to better understand the
pathogenesis and treatment response of this visually threaten-
ing disease.
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